2020
DOI: 10.1016/j.nimb.2019.04.042
|View full text |Cite
|
Sign up to set email alerts
|

Production of intense mass separated 11C beams for PET-aided hadron therapy

Abstract: A novel production system based on the Isotope Separation On-Line (ISOL) method is being developed to produce intense mass separated 11 C beams for PET-aided hadron therapy. In this work, we present a systematic study of the target that was developed for optimized 11 C beam production. A solid boron nitride target (BN) with approximately 21% open porosity was manufactured by spark plasma sintering to provide maximized in-target production yield with enhanced isotope release properties. Operational limitations … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(20 citation statements)
references
References 26 publications
1
19
0
Order By: Relevance
“…Beamtime was devoted to nine different approved projects through the year. It included several developments within the MEDICIS-Promed European Commission Marie Sklodowska-Curie innovative training program with, as examples, the successful separation of Er-169 from externally irradiated Er-168 (13,14) as feasibility tests in preparation for LS2, as well as promising C-11 diffusion studies (19). In total, 5.5 × 10 19 protons have been directed to the ISOLDE HRS target station in 2018, among which 44% could be exploited for the MEDICIS program (i.e., 2.4 × 10 19 protons).…”
Section: : a Full Year Of Operation With The Cern Proton Beammentioning
confidence: 99%
“…Beamtime was devoted to nine different approved projects through the year. It included several developments within the MEDICIS-Promed European Commission Marie Sklodowska-Curie innovative training program with, as examples, the successful separation of Er-169 from externally irradiated Er-168 (13,14) as feasibility tests in preparation for LS2, as well as promising C-11 diffusion studies (19). In total, 5.5 × 10 19 protons have been directed to the ISOLDE HRS target station in 2018, among which 44% could be exploited for the MEDICIS program (i.e., 2.4 × 10 19 protons).…”
Section: : a Full Year Of Operation With The Cern Proton Beammentioning
confidence: 99%
“…Within MEDICIS-Promed [12], new accelerator systems based on the Isotope Separation On-Line (ISOL) method are being developed, tailored for 11 C beam production [13], manipulation and post-acceleration [14,15]. To meet the requirements for effective treatments, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…intense and pure RIBs, and furthermore, to implement a 11 C-based protocol into existing facilities, optimization along the accelerator chain is essential. For the production of intense mass separated 11 C beams, a porous hexagonal boron nitride (BN) ISOL-type target has been developed [13]. Boron-comprising targets are prominent because of the high nuclear reaction cross section 11 B(p,n) 11 C, enabling increased in-target production yields.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…When using 11 C (β + emitter, = 20.4 min) as the primary treatment beam in hadron therapy, one can benefit from its excellent properties for both on-line and off-line PET imaging, which can be used for dose verification [2]. While ions are produced abundantly in conventional hadron therapy with stable carbon, it is highly challenging to provide a radioactive beam of adequate intensity for treatment [3]. In this paper it is assumed that the radioactive treatment ions are produced by the Isotope Separation On-Line (ISOL) technique.…”
Section: Introductionmentioning
confidence: 99%